Found: 7
Select item for more details and to access through your institution.
Effects of dopaminergic stimulation on peripheral markers of apoptosis: relevance to Parkinson's disease.
- Published in:
- Neurological Sciences, 2003, v. 24, n. 3, p. 157, doi. 10.1007/s10072-003-0107-1
- By:
- Publication type:
- Article
Motor complications of Parkinson's disease.
- Published in:
- Neurological Sciences, 2003, v. 24, p. s27, doi. 10.1007/s100720300033
- By:
- Publication type:
- Article
Parkinson's disease and reproductive life events.
- Published in:
- Neurological Sciences, 2002, v. 23, p. S85, doi. 10.1007/s100720200082
- By:
- Publication type:
- Article
Peripheral Markers of Apoptosis in Parkinson's Disease: The Effect of Dopaminergic Drugs.
- Published in:
- Annals of the New York Academy of Sciences, 2004, v. 1010, n. 1, p. 675, doi. 10.1196/annals.1299.123
- By:
- Publication type:
- Article
Effect and safety of duodenal levodopa infusion in advanced Parkinson's disease: a retrospective multicenter outcome assessment in patient routine care.
- Published in:
- Journal of Neural Transmission, 2013, v. 120, n. 11, p. 1553, doi. 10.1007/s00702-013-1026-9
- By:
- Publication type:
- Article
Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson’s disease. The effect of dopaminergic treatment.
- Published in:
- Journal of Neural Transmission, 2004, v. 111, n. 8, p. 1017, doi. 10.1007/s00702-004-0123-1
- By:
- Publication type:
- Article
Modifications of plasma and platelet levels of L-DOPA and its direct metabolites during treatment with tolcapone or entacapone in patients with Parkinson’s disease.
- Published in:
- Journal of Neural Transmission, 2003, v. 110, n. 8, p. 911, doi. 10.1007/s00702-003-0004-z
- By:
- Publication type:
- Article